Mikala Egeblad
NIH Rank #15457
- Program Leader
- R01 Holder
- Translational
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9642804Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-3371-1445Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
- Anatomy & Cell Biology
NIH Funding · FY2026
Linked Award Amount
$685.7K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#15,457
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Mikala Egeblad as a PI. Multi-PI records show the full award amount for context.
- 5R01CA297338-02R01Determining the role of neutrophils in anti-tumor immunity and immune-related adverse events in the context of T cell-based therapies$685.7Kaward amount
- 5U01CA293470-03U01Defining brain-body feedback loops mediating stress-induced metastasis$646.9Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Mikala Egeblad as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardWeill Cornell Medicine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Mikala Egeblad.